» Articles » PMID: 28492048

A Review of the Safety of Cosmetic Procedures During Pregnancy and Lactation

Overview
Publisher Wolters Kluwer
Date 2017 May 12
PMID 28492048
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The safety of cosmetic procedures in patients who are pregnant and/or lactating is a complex clinical question surrounded by uncertainty. Our objective is to consolidate data on the safety of commonly requested cosmetic procedures during pregnancy and lactation after a systematic review of the current literature to guide evidence-based care in the future. A systematic search of the PubMed database was conducted for articles on cosmetic procedures during pregnancy and lactation. Due to a lack of controlled trials, case reports and series were considered. Minor procedures such as shave, punch, snipping, and electrocautery are considered safe. With respect to chemical peels, glycolic and lactic acid peels are deemed safe; however, trichloracetic and salicylic acid peels should be avoided or used with caution. Although safety data on botulinum toxin A is insufficient, the procedure may be safe because systemic absorption and placental transfer are negligible. Sclerotherapy can be safe during pregnancy but must be avoided during the first trimester and after week 36 of the pregnancy. Laser and light therapies have been considered generally safe for patients with granulomatous conditions and condylomata. Epilation should be limited to waxing, shaving, and topical treatments instead of permanent procedures. In patients who are lactating, most therapies discussed above are safe but fat transfer, sclerotherapy, and tumescent liposuction are not recommended. Better evidence is needed to make concrete recommendations on the safety of cosmetic therapy during pregnancy and lactation but preliminary evidence suggests excellent safety profiles for many commonly requested cosmetic procedures.

Citing Articles

Gastrointestinal symptoms and disorders of gut-brain interaction in pregnancy.

Jain A, Ramchandani S, Bhatia S Indian J Gastroenterol. 2025; .

PMID: 39754699 DOI: 10.1007/s12664-024-01705-z.


Nail Society of India Recommendations for Treatment of Onychomycosis in Special Population Groups.

Mahajan K, Grover C, Relhan V, Tahiliani S, Singal A, Shenoy M Indian Dermatol Online J. 2024; 15(2):196-204.

PMID: 38550843 PMC: 10969234. DOI: 10.4103/idoj.idoj_578_23.


Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.

Brin M, Kirby R, Slavotinek A, Manack Adams A, Parker L, Ukah A Neurology. 2023; 101(2):e103-e113.

PMID: 37137724 PMC: 10351549. DOI: 10.1212/WNL.0000000000207375.


Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review.

Ly S, Kamal K, Manjaly P, Barbieri J, Mostaghimi A Dermatol Ther (Heidelb). 2022; 13(1):115-130.

PMID: 36447117 PMC: 9823189. DOI: 10.1007/s13555-022-00854-3.


Dermatologic and Cosmetic Procedures in Pregnancy.

Garg A, Mysore V J Cutan Aesthet Surg. 2022; 15(2):108-117.

PMID: 35965909 PMC: 9364454. DOI: 10.4103/JCAS.JCAS_226_20.


References
1.
Kuhnert B, Philipson E, PIMENTAL R, Kuhnert P, Zuspan K, Syracuse C . Lidocaine disposition in mother, fetus, and neonate after spinal anesthesia. Anesth Analg. 1986; 65(2):139-44. View

2.
Wataganara T, Leelakusolvong S, Sunsaneevithayakul P, Vantanasiri C . Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report. J Perinatol. 2009; 29(9):637-9. DOI: 10.1038/jp.2009.65. View

3.
Chacon A . Fillers in dermatology: from past to present. Cutis. 2015; 96(5):E17-9. View

4.
Tan M, Kim E, Koren G, Bozzo P . Botulinum toxin type A in pregnancy. Can Fam Physician. 2013; 59(11):1183-4. PMC: 3828093. View

5.
Fayans E, Stuart H, Carsten D, Ly Q, Kim H . Local anesthetic use in the pregnant and postpartum patient. Dent Clin North Am. 2010; 54(4):697-713. DOI: 10.1016/j.cden.2010.06.010. View